Viewing Study NCT04746235


Ignite Creation Date: 2025-12-24 @ 10:19 PM
Ignite Modification Date: 2025-12-26 @ 5:38 PM
Study NCT ID: NCT04746235
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-03
First Post: 2021-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module